Synaptojanin 2, a Novel Synaptojanin Isoform with a Distinct Targeting Domain and Expression Pattern*
- From the Department of Cell Biology and Howard Hughes Medical Institute, Yale University, School of Medicine, New Haven, Connecticut 06510
Abstract
Synaptojanin (synaptojanin 1) is a recently identified inositol 5′-phosphatase, which is highly enriched in nerve terminals and is implicated in synaptic vesicle recycling. It is composed of three domains: an amino-terminal SacI homology region, a central inositol 5′-phosphatase homology region, and a carboxyl-terminal proline-rich region. We have now identified and characterized a novel form of synaptojanin, synaptojanin 2, which has a broader tissue distribution. Synaptojanin 2 cDNA from rat brain library encodes a protein of 1,248 amino acids with a predictedM r of 138,268. The two synaptojanin isoforms share 57.2 and 53.8% amino acid identity in their SacI and phosphatase domains, respectively. In marked contrast, their carboxyl-terminal proline-rich regions bear little homology. Expression of synaptojanin 2 in COS7 cells produced a 140-kDa protein with inositol 5′-phosphatase actvity. Protein binding assays demonstrated that among the major src homology 3-proteins known to bind to the proline-rich region of synaptojanin 1, Grb2, amphiphysin, and members of SH3p4/8/13 protein family, only Grb2 bound to that of synaptojanin 2. Furthermore, subcellular fractionation studies in transfected Chinese hamster ovary cells revealed that synaptojanin 2 was predominantly associated with the particulate fraction while synaptojanin 1 was mainly localized in the soluble fraction. This observation suggests that the proline-rich regions of synaptojanins 1 and 2 are implicated in different protein-protein interactions and direct the two isoforms to different subcellular compartments.
Our results demonstrate the presence of a family of synaptojanin-type inositol 5′-phosphatases with different tissue and subcellular distributions, which may be involved in distinct membrane trafficking and signal transduction pathways in mammalian cells.
Footnotes
-
↵* This research was supported in part by the HFSP Program and by Grants CA48128 and NS36251 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBank™/EMBL Data Bank with accession number(s) U90312.
-
↵‡ Present address: MRC/LMCB, University College London, Gower St., London WC1E 6BT, UK.
-
↵§ To whom correspondence should be addressed: Dept. of Cell Biology, Howard Hughes Medical Institute, Boyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Ave., New Haven, CT 06510. Tel.: 203-737-4461; Fax: 203-737-4436; E-mail:pietro.decamilli{at}yale.edu.
-
↵1 The abbreviations used are; SH3, Src homology 3; PCR, polymerase chain reaction; GST, glutathioneS-transferase; MBP, maltose-binding protein; PAGE, polyacrylamide gel electrophoresis; kb, kilobase(s); CHO, Chinese hamster ovary.
-
- Received August 15, 1997.










